The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2017 | IBM Watson in concordance with physician recommendations for cancer treatment
S. P. Somashekhar, MCh, FRCS.Ed, from the Manipal Comprehensive Cancer Center, India, provides us with an insight into the superior efficiency of the IBM Watson for Oncology (WFO) cognitive computing system in recommending treatment regimens for lung cancer and colorectal cancer, in comparison to a multimember multidisciplinary tumor board. This interview was filmed at the American Society of Oncology (ASCO) 2017 Annual Meeting in Chicago, IL.
